YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Serum Myeloperoxidase and Adenosine Deaminase Activities in Polycystic Ovary Syndrome

dc.authorid Kurdoglu, Zehra/0000-0001-5191-1072
dc.authorid Kurdoglu, Mertihan/0000-0002-5344-9739
dc.authorscopusid 14622889300
dc.authorscopusid 36574004100
dc.authorscopusid 24461835200
dc.authorwosid Kurdoglu, Zehra/A-2453-2019
dc.authorwosid Kurdoglu, Mertihan/J-5462-2017
dc.contributor.author Kurdoglu, Z.
dc.contributor.author Ozkol, H.
dc.contributor.author Kurdoglu, M.
dc.date.accessioned 2025-05-10T16:59:49Z
dc.date.available 2025-05-10T16:59:49Z
dc.date.issued 2012
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Kurdoglu Z., Department of Obstetrics and Gynecology, Yuzuncu Yil University, Van, Turkey; Ozkol H., Department of Medical Biology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey; Kurdoglu M., Department of Obstetrics and Gynecology, Yuzuncu Yil University, Van, Turkey en_US
dc.description.abstract Objective: To evaluate serum myeloperoxidase (MPO) and adenosine deaminase activities and to investigate whether there was a correlation between these and sex hormones, and lipids in polycystic ovary syndrome. Design and methods: Forty-five women with polycystic ovary syndrome and 40 healthy controls were included in this study. Leukocyte counts, serum MPO and adenosine deaminase activities, and high-sensitive C-reactive protein (hs-CRP), sex hormone and lipid levels were assessed. Results: Leukocyte counts and serum MPO activities were higher (p<0.01 and p<0.05, respectively) and there was a significant correlation between serum adenosine deaminase and hs-CRP level in women with polycystic ovary syndrome (r=0.853, p<0.01). Serum MPO and adenosine deaminase levels did not correlate with sex hormones or lipid profiles in these patients. Conclusion: Polycystic ovary syndrome may involve an inflammatory process by increasing serum MPO activity independent of sex hormones, body mass index and lipid profiles. © 2012 Informa UK, Ltd. en_US
dc.description.woscitationindex Emerging Sources Citation Index
dc.identifier.doi 10.3109/09513590.2011.583959
dc.identifier.endpage 118 en_US
dc.identifier.issn 1473-0766
dc.identifier.issue 2 en_US
dc.identifier.pmid 21756068
dc.identifier.scopus 2-s2.0-84856102186
dc.identifier.scopusquality Q3
dc.identifier.startpage 115 en_US
dc.identifier.uri https://doi.org/10.3109/09513590.2011.583959
dc.identifier.uri https://hdl.handle.net/20.500.14720/4782
dc.identifier.volume 28 en_US
dc.identifier.wos WOS:000299342400008
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.relation.ispartof Gynecological Endocrinology en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Adenosine Deaminase en_US
dc.subject Inflammation en_US
dc.subject Myeloperoxidase en_US
dc.subject Polycystic Ovary Syndrome en_US
dc.title Serum Myeloperoxidase and Adenosine Deaminase Activities in Polycystic Ovary Syndrome en_US
dc.type Article en_US

Files